Pharmaron Beijing Co., Ltd. (SHE:300759)

Market Cap	50.60B
Revenue (ttm)	12.70B
Net Income (ttm)	1.87B
Shares Out	1.77B
EPS (ttm)	1.06
PE Ratio	28.58
Forward PE	27.68
Dividend	0.20 (0.65%)
Ex-Dividend Date	Jul 4, 2025

Volume	57,658,989
Average Volume	58,949,555
Open	28.80
Previous Close	30.84
Day's Range	28.80 - 31.16
52-Week Range	18.42 - 36.42
Beta	0.93
RSI	64.03
Earnings Date	Aug 22, 2025

About Pharmaron Beijing

Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally. The company offers laboratory chemistry services, including medicinal and synthetic chemistry, chemistry for new modalities, radiolabelling and radiosynthesis, analytical and purification chemistry, DNA-encoded libraries, cheminformatics, and computer-aided drug design; bioscience services, such as structural biology, in vi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 21,370
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300759

Financial Performance

In 2024, Pharmaron Beijing's revenue was 12.28 billion, an increase of 6.39% compared to the previous year's 11.54 billion. Earnings were 1.79 billion, an increase of 12.01%.